Magnetic Resonance of 2-Hydroxyglutarate in IDH1-Mutated Low-Grade Gliomas
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Magnetic Resonance of 2-Hydroxyglutarate in IDH1-Mutated Low-Grade Gliomas
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 4, Issue 116, Pages 116ra5-116ra5
Publisher
American Association for the Advancement of Science (AAAS)
Online
2012-01-12
DOI
10.1126/scitranslmed.3002796
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy
- (2012) O. C. Andronesi et al. Science Translational Medicine
- The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
- (2011) Rasheduzzaman Chowdhury et al. EMBO REPORTS
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Implementation of 3 T Lactate-Edited 3D 1H MR Spectroscopic Imaging with Flyback Echo-Planar Readout for Gliomas Patients
- (2010) Ilwoo Park et al. ANNALS OF BIOMEDICAL ENGINEERING
- IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
- (2010) Peter Paschka et al. JOURNAL OF CLINICAL ONCOLOGY
- Isocitrate Dehydrogenase 1 and 2 Mutations in Cancer: Alterations at a Crossroads of Cellular Metabolism
- (2010) Z. J. Reitman et al. JNCI-Journal of the National Cancer Institute
- Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM
- (2010) R. Srinivasan et al. NEURO-ONCOLOGY
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
- (2010) C. Houillier et al. NEUROLOGY
- Semi-parametric time-domain quantification of HR-MAS data from prostate tissue
- (2010) Helene Ratiney et al. NMR IN BIOMEDICINE
- Cancer-associated IDH mutations: biomarker and therapeutic opportunities
- (2010) K E Yen et al. ONCOGENE
- Monoclonal antibody specific for IDH1 R132H mutation
- (2009) David Capper et al. ACTA NEUROPATHOLOGICA
- Evaluation of the ERETIC method as an improved quantitative reference for1H HR-MAS spectroscopy of prostate tissue
- (2009) Mark J. Albers et al. MAGNETIC RESONANCE IN MEDICINE
- Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package
- (2009) D Stefan et al. MEASUREMENT SCIENCE and TECHNOLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
- Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review
- (2008) Mahdi Aghili et al. JOURNAL OF NEURO-ONCOLOGY
- Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using1H HR-MAS total correlation spectroscopy
- (2008) Mark G. Swanson et al. MAGNETIC RESONANCE IN MEDICINE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now